WallStreetZenWallStreetZen

NASDAQ: CRIS
Curis Inc Stock Forecast, Predictions & Price Target

Analyst price target for CRIS

Based on 1 analyst offering 12 month price targets for Curis Inc.
Min Forecast
$9.00+1,560.52%
Avg Forecast
$9.00+1,560.52%
Max Forecast
$9.00+1,560.52%

Should I buy or sell CRIS stock?

Based on 1 analyst offering ratings for Curis Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRIS stock forecasts and price targets.

CRIS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 37%
64
BuyMaintains$9.00+1,560.52%2022-11-10

1 of 1

CRIS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRIS$0.54$9.00+1,560.52%Buy
HEPA$0.68N/AN/A
VIRX$1.38$19.67+1,325.14%Buy
NBRV$1.74N/AN/A
QNCX$1.48N/AN/A

Curis Stock Forecast FAQ

Is Curis Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CRIS) stock is to Buy CRIS stock.

Out of 1 analyst, 0 (0%) are recommending CRIS as a Strong Buy, 1 (100%) are recommending CRIS as a Buy, 0 (0%) are recommending CRIS as a Hold, 0 (0%) are recommending CRIS as a Sell, and 0 (0%) are recommending CRIS as a Strong Sell.

If you're new to stock investing, here's how to buy Curis stock.

What is CRIS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CRIS price target, the average CRIS price target is $9.00, with the highest CRIS stock price forecast at $9.00 and the lowest CRIS stock price forecast at $9.00.

The Wall Street analyst predicted that Curis's share price could reach $9.00 by Nov 10, 2023. The average Curis stock price prediction forecasts a potential upside of 1,560.52% from the current CRIS share price of $0.54.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.